C. Viswateja Reddy, SK. Meharunnisa*
Volume-12, Issue-1, January 2024, 4585 | Full article PDF
https://doi.org/10.30904/j.ajmps.2024.4585
Available online: Jan 5, 2024
A b s t r a c t
Neurologists now treat an increasing number of strokes as a major public health concern, with neuroprotective medications serving as the cornerstone of care. Further research in this area is necessary because India lacks well-defined studies regarding the clinical symptomatology of stroke medications. The term “stroke” refers to a broad range of disorders involving the blood vessels of the central nervous system. These disorders can arise from either hemorrhaging into the parenchyma or subarachnoid space of the CNS, causing neurologic dysfunction, or from inadequate blood flow to the brain, leading to infarction of the involved portion of the CNS. One of the leading causes of death in the world is stroke. This review looks at a study that was conducted in the past on the drug use habits of stroke of the brain. The study’s objectives are to examine the medications that are prescribed to stroke victims and identify the variables that affect the selection of treatments. The review highlights the most commonly prescribed medications for the treatment of stroke and any potential gaps in medication use. It also provides a summary of the study methodology and findings. It also identifies areas for future research and talks about how the study’s conclusions might improve the outcomes of stroke treatment. In summary, this review offers significant new information about the drug use pattern associated with brain stroke and how it affects patient care and healthcare planning.
Keywords:Drug utilization pattern, Medication adherence, Patient counseling, stroke, dyslipidemia, hypertension.